A

Akebia Therapeutics

Develops CKD anemia therapies

Senior Medical Science Outcomes Liaison

Biology & BiotechConfirmed live in the last 24 hours
Full-timeCalifornia, USA$174.7k - $215.8kIn-person

About the Job

Requirements

  • An advanced clinical or scientific degree, such as an MD, PharmD, PhD, DNP, NP, PA, or equivalent, is required.
  • At least 3 years of pharmaceutical, biotechnology, healthcare, clinical research, or Medical Affairs experience is required.
  • Ability to communicate complex clinical and scientific information to diverse healthcare audiences is required.
  • Understanding of evidence-based medicine, clinical research methodology, and interpretation of scientific literature is required.
  • Experience working independently in a field-based role within a highly regulated environment is required.
  • Ability to travel up to 70% of the time is required.
  • Strong scientific acumen to interpret and communicate clinical, economic, and outcomes evidence is required.
  • Ability to connect scientific insights to healthcare delivery and population health objectives is required.
  • Understanding of organized customer dynamics is required.
  • Ability to engage clinical and executive audiences, including physicians, medical directors, quality leaders, pharmacy leaders, and population health executives, is required.
  • Ability to identify, analyze, and communicate actionable customer insights is required.
  • Strong organizational and project management skills to manage multiple priorities are required.
  • Ability to navigate ambiguity in a dynamic biotechnology environment is required.
  • Commitment to integrity, professionalism, compliance, and ethical conduct is required.

Responsibilities

  • Serve as the designated Medical Affairs partner for assigned National Account Managers and regional strategic dialysis, nephrology, and health system accounts.
  • Collaborate with National Account Managers on account planning by providing scientific, clinical, outcomes, and healthcare ecosystem expertise.
  • Develop and execute Medical Account Plans aligned with Medical Affairs priorities and strategic account objectives.
  • Participate in account reviews and cross-functional planning to identify scientific opportunities and customer needs.
  • Provide scientific support for initiatives focused on clinical outcomes, quality metrics, patient experience, care delivery, and population health performance.
  • Facilitate evidence-based discussions with dialysis organizations, nephrology large group practices, integrated delivery networks, and other organized healthcare customers.
  • Establish and maintain scientific relationships with medical directors, chief medical officers, quality leaders, pharmacy leaders, population health executives, and nephrology clinical leadership.
  • Conduct scientific exchange with stakeholders responsible for clinical policy, treatment pathways, quality improvement initiatives, and value-based care programs.
  • Communicate clinical, health economics and outcomes research, and real-world evidence related to chronic kidney disease, dialysis-dependent chronic kidney disease, anemia management, healthcare resource utilization, and patient outcomes.
  • Support scientific discussions involving quality measures, hospitalization reduction, treatment optimization, patient-centered outcomes, and health equity initiatives.
  • Gather and communicate customer insights about disease management, treatment pathways, healthcare delivery trends, population health priorities, and unmet medical needs.
  • Identify evidence gaps and opportunities for outcomes research, real-world evidence generation, and scientific collaboration.
  • Provide medical and scientific insights to support Medical Affairs, health economics and outcomes research, National Accounts, Clinical Development, and Market Access strategies.
  • Support scientific advisory boards, medical education initiatives, and evidence dissemination activities.
  • Develop and maintain scientific relationships with academic nephrology centers, kidney disease centers of excellence, and rare disease investigators.
  • Identify emerging scientific leaders, referral networks, and key stakeholders within rare kidney disease communities.
  • Provide field-based insights regarding diagnostic pathways, referral patterns, unmet needs, and evolving standards of care.
  • Support future Medical Affairs planning and launch readiness activities for pipeline assets.
  • Serve as medical lead for assigned dialysis organizations, nephrology large group practices, integrated delivery networks, and other organized healthcare customers.
  • Develop and maintain credible scientific relationships with medical, pharmacy, quality, and population health leaders within assigned accounts.
  • Conduct compliant scientific exchange with healthcare professionals, healthcare decision makers, and organized customer stakeholders.
  • Present clinical, health economics and outcomes research, and real-world evidence in response to unsolicited requests and approved scientific exchange opportunities.
  • Support dissemination of scientific information related to approved products, disease states, and relevant pipeline programs.
  • Collaborate with Medical Affairs, Market Access, and National Accounts to address customer scientific needs.
  • Facilitate investigator-initiated studies, outcomes research initiatives, and evidence-generation opportunities consistent with company policies.
  • Participate in national and regional scientific meetings, nephrology congresses, dialysis organization meetings, and population health conferences.
  • Support healthcare system collaborations and medical education programs.
  • Maintain compliance, scientific integrity, and ethical conduct in all interactions.

Desired Qualifications

  • At least 5 years of experience in Medical Affairs, Medical Science Liaison, Medical Science Outcomes Liaison, Medical Outcomes Liaison, health economics and outcomes research, Market Access, or related healthcare roles is preferred.
  • Experience in nephrology, chronic kidney disease, dialysis, anemia, cardiovascular-renal-metabolic disease, or related therapeutic areas is preferred.
  • Understanding of the United States healthcare delivery system, including provider, payer, and population health stakeholders, is preferred.
  • Experience engaging organized healthcare customers, including dialysis organizations, integrated delivery networks, accountable care organizations, nephrology large group practices, and health systems, is preferred.
  • Knowledge of value-based care models, quality measurement frameworks, population health management, and healthcare performance improvement initiatives is preferred.
  • Experience communicating health economics and outcomes research, real-world evidence, epidemiology, healthcare resource utilization, and quality outcomes data is preferred.
  • Understanding of formulary decision-making processes, healthcare quality metrics, and evidence requirements used by healthcare organizations is preferred.
  • Experience supporting strategic account planning and collaborating with National Account Managers, Market Access teams, or organized customer-facing functions is preferred.
  • Working knowledge of dialysis reimbursement, end-stage renal disease payment systems, Centers for Medicare & Medicaid Services quality programs, and kidney care delivery models is preferred.
  • Familiarity with clinical practice guidelines and treatment pathways relevant to chronic kidney disease and dialysis-dependent chronic kidney disease is preferred.
  • Experience engaging academic medical centers, nephrology centers of excellence, or clinical investigators is preferred.
  • Familiarity with rare disease development, orphan drug commercialization, and rare disease patient journeys is preferred.
  • Understanding of referral pathways, diagnostic challenges, and care coordination within rare kidney diseases is preferred.
  • Experience supporting clinical trial awareness, site engagement, investigator identification, or evidence-generation activities is preferred.

About the Company

Akebia Therapeutics

Develops CKD anemia therapies

Akebia Therapeutics focuses on developing and commercializing therapies for chronic kidney disease (CKD), especially anemia related to CKD. Its lead product candidate, vadadustat, is in global Phase 3 trials. The company conducts research, clinical development, and strategic partnerships to bring therapies to market, generating revenue from product sales, licensing, and collaborations. Akebia's goal is to improve the quality of life for CKD patients by providing effective treatments through a science-driven biopharmaceutical approach based in Cambridge, MA.

Company size
201-500
Company stage
IPO
Headquarters
Cambridge, MA
Founded
2007

Recently Posted Jobs

Explore more opportunities at Akebia Therapeutics

See more jobs